To improve the diagnosis of NAFLD and the prediction of its progression, more studies are needed to reveal the pathological mechanistic pathways involved in NAFLD and insulin sensitivity in patients with obesity and T2DM. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.